Research field (4):
Pharmaceuticals - analytical and physicochemistry
, Immunology
, Pharmaceuticals - analytical and physicochemistry
, Pharmaceuticals - health and biochemistry
Research keywords (1):
抗体 Fab
Research theme for competitive and other funds (8):
2020 - 2023 超耐熱化蛋白質融合抗体フラグメントの創製
2016 - 2020 Thermostabilization of Fab and its application to medicine
2013 - 2017 Study on structure, function and gene regulation of Protobothrops flavoviridis snake venom phospholipase A2 isozymes
2011 - 2012 Analysis ofthe relationship between tchoenformational stabilityof phospholipaseA2 and the amount of IgG production.
Moeka Yoshikawa, Miki Senda, Hitomi Nakamura, Naoko Oda-Ueda, Tadashi Ueda, Toshiya Senda, Takatoshi Ohkuri. Stabilization of adalimumab Fab through the introduction of disulfide bonds between the variable and constant domains. Biochemical and Biophysical Research Communications. 2024. 700. 149592-149592
Kosuke Oyama, Makoto Nakakido, Takatoshi Ohkuri, Hitomi Nakamura, Kouhei Tsumoto, Tadashi Ueda. Enhancing thermal stability in the CH2 domain to suppress aggregation through the introduction of simultaneous disulfide bonds in Pichia pastoris. Protein science : a publication of the Protein Society. 2023. 32. 12. e4831
Moeka Yoshikawa, Hitomi Nakamura, Naoko Oda-Ueda, Tadashi Ueda, Takatoshi Ohkuri. Effect of an intermolecular disulfide bond introduced into the first loop of CH1 domain of Adalimumab Fab on thermal stability and antigen-binding activity. The Journal of Biochemistry. 2022. 172. 1. 49-56
Hitomi Nakamura, Moeka Yoshikawa, Naoko Oda-Ueda, Tadashi Ueda, Takatoshi Ohkuri. A comprehensive analysis of novel disulfide bond introduction site into the constant domain of human Fab. Scientific Reports. 2021. 11. 1
Oyama K, Ohkuri T, Ochi J, Caaveiro JMM, Ueda T. Abolition of aggregation of CH 2 domain of human IgG1 when combining glycosylation and protein stabilization. Biochem Biophys Res Commun. 2021. 18. 558. 114-119
Yoshikawa M, Nakamura H, Oda-Ueda N, Ohkuri T. Analysis of thermostability for seven Phe to Ala and six Pro to Gly mutants in the Fab constant region of adalimumab. The Journal of Biochemistry. 2023. 174. 4. 345-353
中村仁美, 大栗誉敏, 服部正策, 上田直子. Neutralizing effects of monoclonal antibodies against the myotoxic factor (BPII) from Protobothrops flavoviridis venom and the development of related Fab fragments. 日本薬学会年会要旨集(CD-ROM). 2020. 140th